Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases and conditions
申请人:Hellberg R. Mark
公开号:US20060142307A1
公开(公告)日:2006-06-29
Methods for using aminopyrazine analogs to treat rho kinase-mediated diseases or rho kinase-mediated conditions, including controlling intraocular pressure and treating glaucoma, are disclosed. Ophthalmic pharmaceutical compositions useful in the treatment of eye diseases such as glaucoma, and additionally useful for controlling intraocular pressure, the compositions comprising an effective amount of aminopyrazine analogs, are also disclosed.
Towards aryl C–N bond formation in dynamic thin films
作者:Michael N. Gandy、Colin L. Raston、Keith A. Stubbs
DOI:10.1039/c4ob00926f
日期:——
CâN bond forming reactions are important in organic chemistry. A thin film microfluidic vortex fluidic device (VFD) operating under confined mode affords N-aryl compounds from 2-chloropyrazine and the corresponding amine, without the need for a transition metal catalyst.
AMINOPYRAZINE ANALOGS FOR TREATING GLAUCOMA AND OTHER RHO KINASE-MEDIATED DISEASES
申请人:ALCON INC.
公开号:EP1830853A2
公开(公告)日:2007-09-12
JP2004534057A
申请人:——
公开号:JP2004534057A
公开(公告)日:2004-11-11
[EN] AMINOPYRAZINE ANALOGS FOR TREATING GLAUCOMA AND OTHER RHO KINASE-MEDIATED DISEASES AND CONDITIONS<br/>[FR] ANALOGUES D'AMINOPYRAZINE SERVANT A TRAITER LE GLAUCOME ET D'AUTRES MALADIES OU ETATS MEDIES PAR RHO KINASE
申请人:ALCON INC
公开号:WO2006071548A2
公开(公告)日:2006-07-06
[EN] Methods for using aminopyrazine analogs to treat rho kinase-mediated diseases or rho kinase-mediated conditions, including controlling intraocular pressure and treating glaucoma, are disclosed. Ophthalmic pharmaceutical compositions useful in the treatment of eye diseases such as glaucoma, and additionally useful for controlling intraocular pressure, the compositions comprising an effective amount of aminopyrazine analogs, are also disclosed. [FR] L'invention concerne des méthodes visant à utiliser des analogues d'aminopyrazine afin de traiter des maladies ou des états médiés par rho kinase, ainsi que de contrôler la pression intra-oculaire et traiter le glaucome. Elle concerne également des compositions pharmaceutiques ophtalmiques utiles pour traiter des maladies oculaires, telles que le glaucome et également utiles pour contrôler la pression intra-oculaire, ces compositions contenant une quantité efficace d'analogues d'aminopyrazine.